Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1780706 | 1.00 | HIF1A (0.33) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL1781456 | 1.00 | HIF1A (0.33) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL12095338 | 1.00 | HIF1A (0.33) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL284489 | 1.00 | — | — | |
| SCHEMBL6518187 | 0.97 | HIF1A (0.32) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL1782493 | 0.94 | — | — | |
| SCHEMBL148995 | 0.94 | — | — | |
| SCHEMBL1864746 | 0.91 | — | — | |
| SCHEMBL1783195 | 0.91 | — | — | |
| SCHEMBL1782807 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1004 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | UNIV MUENCHEN TECH (DE) | 2026-01-22 | — | — | US | claimed |
| EP-4648800-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | Genmab A/S (DK) | 2025-11-19 | — | — | EP | claimed |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | Technische Universität München (DE) | 2025-08-19 | — | — | US | claimed |
| WO-2025034668-A9 | LANTHANIDE-BASED CONTRAST AGENTS HAVING IMPROVED STABILITY AND METHODS FOR THEIR PRODUCTION AND PURIFICATION | Inventure, LLC (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025034668-A1 | LANTHANIDE-BASED CONTRAST AGENTS HAVING IMPROVED STABILITY AND METHODS FOR THEIR PRODUCTION AND PURIFICATION | Inventure, LLC (US) | 2025-02-13 | — | — | WO | claimed |
| US-20250041460-A1 | LANTHANIDE-BASED CONTRAST AGENTS HAVING IMPROVED STABILITY AND METHODS FOR THEIR PRODUCTION AND PURIFICATION | Inventure, LLC (US) | 2025-02-06 | — | — | US | claimed |
| EP-4291250-B1 | DUAL MODE RADIOTRACER AND THERAPEUTICS | UNIV MUENCHEN TECH (DE) | 2025-01-15 | — | — | EP | claimed |
| CN-119236123-A | HSP 90-targeting conjugates and formulations thereof | 融合制药公司 | 2025-01-03 | — | — | CN | claimed |
| US-20240399001-A1 | RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP) | Blue Earth Diagnostics Limited (GB) | 2024-12-05 | — | — | US | claimed |
| CN-119032157-A | Microelectronic device cleaning compositions | 恩特格里斯公司 | 2024-11-26 | — | — | CN | claimed |
| WO-1998042383-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | claimed |
| EP-0545983-B1 | INTERMEDIATES FOR CHELATING AGENTS WITH PREFIXED SYMMETRY AND PROCESS FOR THEIR PREPARATION | BRACCO SPA (IT) | 1994-10-26 | — | — | EP | claimed |
| US-5354554-A | Crosslinked antibodies and processes for their preparation | CELLTECH LIMITED (GB) | 1994-10-11 | — | — | US | claimed |
| EP-0433312-A4 | CARRIER SYSTEM AND METHOD FOR ENHANCEMENT OF MAGNETIC RESONANCE IMAGING | — | 1991-12-04 | — | — | EP | claimed |
| EP-0453082-A1 | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent | HYBRITECH INCORPORATED (US) | 1991-10-23 | — | — | EP | claimed |
| EP-0433312-A1 | CARRIER SYSTEM AND METHOD FOR ENHANCEMENT OF MAGNETIC RESONANCE IMAGING | THE UNIVERSITY OF CONNECTICUT (US) | 1991-06-26 | — | — | EP | claimed |
| US-4915933-A | Nuclear magnetic resonance | THE UNIVERSITY OF NEW MEXICO (US) | 1990-04-10 | — | — | US | claimed |
| WO-1990001900-A1 | CARRIER SYSTEM AND METHOD FOR ENHANCEMENT OF MAGNETIC RESONANCE IMAGING | THE UNIVERSITY OF CONNECTICUT (US) | 1990-03-08 | — | — | WO | claimed |
| EP-0263861-A1 | LYSINE SALT OF THE GADOLINIUM-DOTA COMPLEX AND ITS APPLICATIONS TO DIAGNOSIS. | GUERBET SA (FR) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006229-A1 | LYSINE SALT OF THE GADOLINIUM-DOTA COMPLEX AND ITS APPLICATIONS TO DIAGNOSIS | GUERBET S.A. (FR) | 1987-10-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | FOLH1, SLC19A1, KLK3 | HIF1A 424/4885MAPT 3073/4885PDE4A 4822/4885 |
| US-20240399001-A1 | RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP) | FAP, FIBP, FGFR1 | HIF1A 920/4885MAPT 2805/4885PDE4A 2692/4885 |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | PAICS, SSTR2, SSTR1 | HIF1A 499/4885MAPT 1832/4885PDE4A 4728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.